For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
A–Z: On the cards for health in 2025
+Opinion
In print
Commentary
A–Z: On the cards for health in 2025
Tuesday 4 February 2025, 11:25 AM

Already puzzled by what’s ahead in 2025, even as the health portfolio does a flip and sees a health-sector novice, aka Simeon Brown, replace sector veteran Shane Reti? Editor Barbara Fountain racks her brain to turn out a last-minute A-Z refresh
A: AI, AI (artificial intelligence) tools were hot items in 2024, gaining a following in an increasing number of surgeries, particularly for note-taking in c
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.